These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26484402)

  • 1. Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drug.
    Staack RF; Jordan G; Viert M; Schäfer M; Papadimitriou A; Heinrich J
    Bioanalysis; 2015 Dec; 7(24):3097-106. PubMed ID: 26484402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
    Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
    Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of drug specific circulating immune complexes from in vivo cynomolgus monkey serum samples.
    Pierog P; Krishna M; Yamniuk A; Chauhan A; DeSilva B
    J Immunol Methods; 2015 Jan; 416():124-36. PubMed ID: 25462536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
    Zoghbi J; Xu Y; Grabert R; Theobald V; Richards S
    J Immunol Methods; 2015 Nov; 426():62-9. PubMed ID: 26255760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing specificity for immunogenicity assays.
    Swanson SJ; Chirmule N
    Bioanalysis; 2009 Jun; 1(3):611-7. PubMed ID: 21083156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation.
    Wessels U; Schick E; Ritter M; Kowalewsky F; Heinrich J; Stubenrauch K
    Bioanalysis; 2017 Jun; 9(11):849-859. PubMed ID: 28517957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
    Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
    J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragment.
    Broders O; Wessels U; Zadak M; Beckmann R; Stubenrauch K
    Bioanalysis; 2020 Apr; 12(8):509-517. PubMed ID: 32351119
    [No Abstract]   [Full Text] [Related]  

  • 9. An ex vivo potency assay to assess active drug levels of a GLP-1 agonistic peptide during preclinical safety studies.
    Schäfer M; Challand S; Schick E; Bader S; Hainzl D; Heinig K; Müller L; Papadimitriou A; Heinrich J
    Bioanalysis; 2015 Dec; 7(24):3063-72. PubMed ID: 26440381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute quantification of the total and antidrug antibody-bound concentrations of recombinant human α-glucosidase in human plasma using protein G extraction and LC-MS/MS.
    Bronsema KJ; Bischoff R; Pijnappel WW; van der Ploeg AT; van de Merbel NC
    Anal Chem; 2015 Apr; 87(8):4394-401. PubMed ID: 25802928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
    Xu W; Jiang H; Titsch C; Haulenbeek JR; Pillutla RC; Aubry AF; DeSilva BS; Arnold ME; Zeng J; Dodge RW
    J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative use of LC-MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay development.
    Jiang H; Xu W; Titsch CA; Furlong MT; Dodge R; Voronin K; Allentoff A; Zeng J; Aubry AF; DeSilva BS; Arnold ME
    Anal Chem; 2014 Mar; 86(5):2673-80. PubMed ID: 24506335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on exploring hybrid LBA/LC-MS approach for clinical immunogenicity testing.
    Jiang H; Myler H; Zeng J; Mora J; Kolaitis G; Pillutla R
    Bioanalysis; 2019 Sep; 11(17):1605-1617. PubMed ID: 31208198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates.
    Hoofring SA; Lopez R; Hock MB; Kaliyaperumal A; Patel SK; Swanson SJ; Chirmule N; Starcevic M
    Bioanalysis; 2013 May; 5(9):1041-55. PubMed ID: 23641695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online 2D-LC-MS/MS assay to quantify therapeutic protein in human serum in the presence of pre-existing antidrug antibodies.
    Shen Y; Zhang G; Yang J; Qiu Y; McCauley T; Pan L; Wu J
    Anal Chem; 2015 Aug; 87(16):8555-63. PubMed ID: 26237058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibody.
    Law WS; Genin JC; Miess C; Treton G; Warren AP; Lloyd P; Dudal S; Krantz C
    Bioanalysis; 2014; 6(23):3225-35. PubMed ID: 25529889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory considerations for development of bioanalytical assays for biotechnology products.
    Swann PG; Shapiro MA
    Bioanalysis; 2011 Mar; 3(6):597-603. PubMed ID: 21417729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Ella
    Wessels U; Mackeben K; Stubenrauch K
    Bioanalysis; 2019 Feb; 11(3):153-164. PubMed ID: 30628464
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges in developing antidrug antibody screening assays.
    Dodge R; Daus C; Yaskanin D
    Bioanalysis; 2009 Jul; 1(4):699-704. PubMed ID: 21083131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.